Lindbrook Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$149K Buy
1,473
+1,392
+1,719% +$136K 0.01% 515
2024
Q4
$7.48K Buy
81
+2
+3% +$196 ﹤0.01% 1802
2024
Q3
$7.63K Sell
79
-39
-33% -$3.5K ﹤0.01% 1814
2024
Q2
$10.1K Buy
118
+64
+119% +$5.37K ﹤0.01% 1614
2024
Q1
$4.46K Buy
54
+12
+29% +$879 ﹤0.01% 1943
2023
Q4
$2.8K Sell
42
-4
-9% -$259 ﹤0.01% 2151
2023
Q3
$3.09K Buy
46
+7
+18% +$481 ﹤0.01% 1972
2023
Q2
$2.64K Hold
39
﹤0.01% 2040
2023
Q1
$2.11K Buy
+39
New +$2.27K ﹤0.01% 2224
2022
Q4
Sell
-12
Closed -$1K 2881
2022
Q3
$1K Sell
12
-17
-59% -$850 ﹤0.01% 2303
2022
Q2
$1K Sell
29
-118
-80% -$6.05K ﹤0.01% 2213
2022
Q1
$8K Sell
147
-70
-32% -$3.65K ﹤0.01% 1370
2021
Q4
$11K Buy
217
+115
+113% +$5.93K ﹤0.01% 1225
2021
Q3
$6K Sell
102
-7
-6% -$440 ﹤0.01% 1175
2021
Q2
$7K Hold
109
﹤0.01% 1180
2021
Q1
$7K Buy
109
+7
+7% +$457 ﹤0.01% 1142
2020
Q4
$7K Hold
102
﹤0.01% 1035
2020
Q3
$5K Buy
102
+11
+12% +$564 ﹤0.01% 1100
2020
Q2
$4K Sell
91
-6
-6% -$324 ﹤0.01% 1146
2020
Q1
$5K Buy
+97
New +$5.59K ﹤0.01% 977

Other funds holding EHC

Lindbrook Capital's EHC Position: Q1 2025 in Review

Lindbrook Capital increased its Encompass Health (EHC) stake by 1,719% in Q1 2025, buying an estimated $136K and bringing the position to 1,473 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #515.

Lindbrook Capital first reported a position in EHC in Q1 2020 and has held it in 20 quarters since. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Lindbrook Capital held 1,473 shares of Encompass Health worth $149K as of Q1 2025.
  • Lindbrook Capital bought 1,392 Encompass Health shares in Q1 2025, an estimated $136K.
  • Encompass Health made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #515 holding.
  • Lindbrook Capital first reported a position in Encompass Health in Q1 2020 and has held it in 20 quarters since.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.